Reenita Das | Partner
Frost & Sullivan | United States

Reenita Das, Partner, Frost & Sullivan

Reenita Das is an industry expert with +25 years of healthcare marketing and consulting experience which include engaging with global clients and start ups to develop and implement growth strategies. She is a passionate visionary, futurist, innovator and thought leader working towards changing healthcare. Das currently serves as Transformational Health Partner and Senior Vice President and is the first woman Partner at Frost & Sullivan.

In her current role, Das works on futuristic forecasts and understanding the place of healthcare 20 years from today, working with clients on the impact of these mega trend changes to their business. Additionally, she works on best practices and mapping of core capabilities, understanding of emerging markets and the challenges of the complex business scenario enabling unique strategies to penetrate and operate efficiently, and identifying opportunities with companies outside of healthcare to bring  solutions to the healthcare sector. She also specializes in medical devices and medical technology, connected health applications, pharmaceuticals and diagnostics, and related industries such as CMOs and CROs, regulatory, logistics, information and communication technology.


Phar-East Day 1 @ 09:40

Pharma Trends: Women health as the next focus

Women’s health goes beyond mother & childcare. For instance, women has a higher risk of cardiovascular diseases compared to men, hence there is a need to invest more on addressing the biological differences in mainstream disease studies to ensure a more effective, personalised treatment. In addition, big data & AI application on female subjects may also differ from male subjects, prompting a need to investigate how studies should be developed differently in the future. This panel brings experts to debate and discuss how femtech is shaping to be the next global pharma focus and the new areas of focus in women's healthcare.

Phar-East Day 1 @ 11:20

The transformation of the Bio pharma industry. Top growth opportunities for 2025

last published: 15/Feb/19 11:45 GMT

back to speakers






For speaking, sponsorship and exhibition opportunities contact
Tel: +65 6322 2738